Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| TDOC | Catapano Joseph Ronald | Chief Accounting Officer | 09/02/2026 | Verkauf | 6.30 | 274 | 1,726 | Form 4 |
| TDOC | Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | 09/02/2026 | Verkauf | 6.30 | 7,573 | 47,717 | Form 4 |
| TDOC | Divita Charles Iii | CHIEF EXECUTIVE OFFICER | 09/02/2026 | Verkauf | 6.30 | 18,327 | 115,478 | Form 4 |
| TARS | Lin Elizabeth Yeu | Chief Medical Officer | 09/02/2026 | Verkauf | 80.00 | 1,590 | 127,200 | Form 4 |
| TARS | Lin Elizabeth Yeu | Chief Medical Officer | 09/02/2026 | Verkauf | 80.00 | 5,387 | 430,960 | Form 4 |
| TARS | Azamian Bobak R. | President/CEO and Board Chair | 09/02/2026 | Verkauf | 80.06 | 10,000 | 800,600 | Form 4 |
| TRNS | Dominach Oksana S. | Director | 09/02/2026 | Verkauf | 85.60 | 7,312 | 625,876 | Form 4 |
| TDW | Hudson Daniel A. | EVP, CLO & Corporate Secretary | 09/02/2026 | Verkauf | 99.08 | 15,000 | 1,486,200 | Form 4 |
| TDW | Traub Kenneth | Director | 09/02/2026 | Verkauf | 99.00 | 10,000 | 990,000 | Form 4 |
| THC | West Nadja | Director | 09/02/2026 | Verkauf | 258.80 | 1,152 | 298,138 | Form 4 |
| TAK | Plump Andrew Stewart | President, R&D | 09/02/2026 | Verkauf | 18.49 | 116,191 | 2,148,372 | Form 4 |
| TILE | Hendrix Daniel T | Director | 09/02/2026 | Verkauf | 37.13 | 8,000 | 297,040 | Form 4 |
| TRDA | Mpm Bioventures 2018, L.p. | 10% Owner | 09/02/2026 | Verkauf | 7.19 | 25,131 | 180,692 | Form 4 |
| TRDA | MPM BioVentures 2014, L.P. | 10% Owner | 09/02/2026 | Verkauf | 7.19 | 25,131 | 180,692 | Form 4 |
| TDUP | Homer Christopher | Chief Operating Officer | 09/02/2026 | Verkauf | 2.58 | 14,135 | 36,485 | Form 4 |
| TDUP | Homer Christopher | Chief Operating Officer | 09/02/2026 | Verkauf | 2.58 | 19,463 | 50,238 | Form 4 |
| TDUP | Homer Christopher | Chief Operating Officer | 09/02/2026 | Verkauf | 2.58 | 26,632 | 68,743 | Form 4 |
| TDUP | Reinhart James G. | Chief Executive Officer | 09/02/2026 | Verkauf | 2.58 | 27,068 | 69,868 | Form 4 |
| TDUP | Reinhart James G. | Chief Executive Officer | 09/02/2026 | Verkauf | 2.58 | 57,771 | 149,119 | Form 4 |
| TDUP | Reinhart James G. | Chief Executive Officer | 09/02/2026 | Verkauf | 2.58 | 86,223 | 222,559 | Form 4 |
| TDUP | Sobers Sean | Chief Financial Officer | 09/02/2026 | Verkauf | 2.58 | 12,218 | 31,537 | Form 4 |
| TDUP | Sobers Sean | Chief Financial Officer | 09/02/2026 | Verkauf | 2.58 | 13,368 | 34,505 | Form 4 |
| TDUP | Sobers Sean | Chief Financial Officer | 09/02/2026 | Verkauf | 2.58 | 18,973 | 48,973 | Form 4 |
| TRMK | Eduardo Marcelo L | Director | 09/02/2026 | Verkauf | 45.64 | 530 | 24,187 | Form 4 |
| TLS | Robbins Edward Hutchinson Jr. | EVP, General Counsel | 09/02/2026 | Verkauf | 4.73 | 62,398 | 295,143 | Form 4 |
| TRU | Skinner Todd C. | President, International | 09/01/2026 | Verkauf | 84.42 | 1,000 | 84,420 | Form 4 |
| TRU | Chaouki Steven M | President, US Markets | 09/01/2026 | Verkauf | 84.42 | 1,000 | 84,420 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 09/01/2026 | Verkauf | 64.63 | 1,000 | 64,630 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 09/01/2026 | Verkauf | 63.80 | 5,900 | 376,420 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 09/01/2026 | Verkauf | 62.64 | 10,900 | 682,776 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 09/01/2026 | Verkauf | 62.12 | 13,046 | 810,418 | Form 4 |
| TEM | Doudna Jennifer A | Director | 09/01/2026 | Verkauf | 65.55 | 676 | 44,312 | Form 4 |
| TEM | Epstein David R | Director | 09/01/2026 | Verkauf | 65.55 | 250 | 16,388 | Form 4 |
| TARS | Lin Elizabeth Yeu | Chief Medical Officer | 09/01/2026 | Verkauf | 73.86 | 4,601 | 339,830 | Form 4 |
| TRGP | Chung Paul W | Director | 09/01/2026 | Verkauf | 297.00 | 816 | 242,352 | Form 4 |
| TRGP | Chung Paul W | Director | 09/01/2026 | Verkauf | 295.38 | 1,000 | 295,381 | Form 4 |
| TNGX | Crystal Adam | President, R&D | 09/01/2026 | Verkauf | 22.37 | 27,000 | 603,909 | Form 4 |
| TRDA | Mpm Bioventures 2018, L.p. | 10% Owner | 09/01/2026 | Verkauf | 7.06 | 29,088 | 205,361 | Form 4 |
| TRDA | MPM BioVentures 2014, L.P. | 10% Owner | 09/01/2026 | Verkauf | 7.06 | 29,088 | 205,361 | Form 4 |
| TER | Johnson Mercedes | Director | 09/01/2026 | Verkauf | 341.30 | 167 | 56,997 | Form 4 |
| TPC | Tutor Ronald N | Director | 08/31/2026 | Verkauf | 85.57 | 800,000 | 68,456,000 | Form 4 |
| TPC | Tutor Ronald N | Director | 08/31/2026 | Verkauf | 85.57 | 1,500,000 | 128,355,000 | Form 4 |
| TPC | Tutor Ronald N | Director | 08/31/2026 | Verkauf | 89.86 | 10,000 | 898,600 | Form 4 |
| TRU | Williams Jennifer A. | SVP, Chief Accounting Officer | 08/31/2026 | Verkauf | 84.57 | 1,070 | 90,490 | Form 4 |
| TMO | Pettiti Gianluca | President & COO | 08/31/2026 | Verkauf | 614.38 | 3,733 | 2,293,481 | Form 4 |
| TMO | Pettiti Gianluca | President & COO | 08/31/2026 | Verkauf | 614.38 | 400 | 245,752 | Form 4 |
| TFSL | Anderson Barbara J. | Director | 08/31/2026 | Verkauf | 17.83 | 6,100 | 108,763 | Form 4 |
| THC | Foo Lisa Y | EVP, Chief Operating Officer | 08/31/2026 | Verkauf | 266.32 | 24,000 | 6,391,680 | Form 4 |
| TRDA | Mpm Bioventures 2018, L.p. | 10% Owner | 08/31/2026 | Verkauf | 6.99 | 44,259 | 309,370 | Form 4 |
| TRDA | MPM BioVentures 2014, L.P. | 10% Owner | 08/31/2026 | Verkauf | 6.99 | 44,259 | 309,370 | Form 4 |
| TEM | West Nadja | Director | 08/28/2026 | Verkauf | 69.00 | 3,000 | 207,000 | Form 4 |
| TTGT | Niemiec Steven | Chief Revenue Officer | 08/28/2026 | Verkauf | 3.85 | 21,427 | 82,485 | Form 4 |
| TYL | Moore H Lynn Jr | President and CEO | 08/28/2026 | Verkauf | 372.79 | 9,250 | 3,448,280 | Form 4 |
| TRUP | Gallagher John R | Chief Operating Officer | 08/28/2026 | Verkauf | 29.70 | 3,604 | 107,039 | Form 4 |
| TRV | Olivo Maria | EVP, ERM & Chief Risk Officer | 08/28/2026 | Verkauf | 369.86 | 6,000 | 2,219,145 | Form 4 |
| TFSL | Weil Meredith S | Chief Financial Officer | 08/28/2026 | Verkauf | 18.00 | 600 | 10,800 | Form 4 |
| TRDA | Mpm Bioventures 2018, L.p. | 10% Owner | 08/28/2026 | Verkauf | 7.01 | 3,733 | 26,168 | Form 4 |
| TRDA | MPM BioVentures 2014, L.P. | 10% Owner | 08/28/2026 | Verkauf | 7.01 | 3,733 | 26,168 | Form 4 |
| TEAM | Liu Gene | Chief Accounting Officer | 08/28/2026 | Verkauf | 190.00 | 939 | 178,410 | Form 4 |
| TNET | Chamberlain Paul Edward | Director | 08/27/2026 | Verkauf | 69.70 | 2,400 | 167,280 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).